MX350866B - Uso de micelas de proteina de suero de leche para infantes en riesgo de obesidad o diabetes. - Google Patents

Uso de micelas de proteina de suero de leche para infantes en riesgo de obesidad o diabetes.

Info

Publication number
MX350866B
MX350866B MX2014004802A MX2014004802A MX350866B MX 350866 B MX350866 B MX 350866B MX 2014004802 A MX2014004802 A MX 2014004802A MX 2014004802 A MX2014004802 A MX 2014004802A MX 350866 B MX350866 B MX 350866B
Authority
MX
Mexico
Prior art keywords
whey protein
infants
protein micelles
diabetes
risk
Prior art date
Application number
MX2014004802A
Other languages
English (en)
Other versions
MX2014004802A (es
Inventor
Mace Catherine
Pouteau Etienne
Jean Rene Bovetto Lionel
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47045036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX350866(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2014004802A publication Critical patent/MX2014004802A/es
Publication of MX350866B publication Critical patent/MX350866B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a micelas de proteínas del suero de leche para uso en el tratamiento y/o prevención de un trastorno asociado a un aumento en la secreción de insulina y/o concentración plasmática de IGF-1 en un infante en riesgo de desarrollar obesidad o diabetes. La invención también se relaciona a una composición nutricional para infantes que comprende micelas de proteínas del suero de leche. Adicionalmente, la invención se relaciona a un uso no terapéutico de una composición nutricional para infantes, comprendiendo micelas de proteínas del suero de leche.
MX2014004802A 2011-10-21 2012-10-19 Uso de micelas de proteina de suero de leche para infantes en riesgo de obesidad o diabetes. MX350866B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11186141.5A EP2583562A1 (en) 2011-10-21 2011-10-21 Use of whey protein micelles for infants at risk of obesity or diabetes
PCT/EP2012/070718 WO2013057233A1 (en) 2011-10-21 2012-10-19 Use of whey protein micelles for infants at risk of obesity or diabetes

Publications (2)

Publication Number Publication Date
MX2014004802A MX2014004802A (es) 2015-12-03
MX350866B true MX350866B (es) 2017-09-22

Family

ID=47045036

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004802A MX350866B (es) 2011-10-21 2012-10-19 Uso de micelas de proteina de suero de leche para infantes en riesgo de obesidad o diabetes.

Country Status (10)

Country Link
US (1) US10028978B2 (es)
EP (2) EP2583562A1 (es)
CN (1) CN103906440B (es)
AU (1) AU2012324887B2 (es)
BR (1) BR112014009225A8 (es)
CL (1) CL2014000865A1 (es)
ES (1) ES2643892T3 (es)
MX (1) MX350866B (es)
RU (1) RU2616525C2 (es)
WO (1) WO2013057233A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
SI3091973T1 (sl) * 2013-11-01 2018-10-30 N.V. Nutricia Lipidni sestavek za izboljšanje sestave telesa med dohitevanjem rasti
CN105764355A (zh) * 2013-11-25 2016-07-13 雀巢产品技术援助有限公司 乳基营养组合物与胃部不适
RU2694827C1 (ru) * 2013-11-29 2019-07-17 Нестек С.А. Детское питание для улучшения чувствительности к инсулину в дальнейшей жизни
US11252986B2 (en) 2013-11-29 2022-02-22 Societe Des Produits Nestle S.A. Use of nutritional compositions having a low protein amount
WO2015085555A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. Array of age-tailored infant formula with optimum protein content and lactose content
PL3361885T3 (pl) 2015-10-15 2019-11-29 Nutricia Nv Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu
ES2866349T3 (es) 2016-12-09 2021-10-19 Nutricia Nv Composición nutricional para mejorar las membranas celulares
WO2018130595A1 (en) * 2017-01-11 2018-07-19 Nestec S.A. Heat sterilized high protein spoonable nutritional compositions with whey protein which comprises whey protein micelles and a source of casein
CN110381964A (zh) * 2017-03-03 2019-10-25 森永乳业株式会社 Glp-1分泌促进剂和组合物
EP4356961A3 (en) * 2019-06-13 2024-07-31 Société des Produits Nestlé S.A. Use of whey protein micelles for controlling postprandial glucose response
MX2022005462A (es) * 2019-11-08 2022-05-26 Abbott Lab Exosomas en polvo aislados de la leche bovina, composiciones alimenticias y metodos.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683492B2 (ja) * 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
JP2001513571A (ja) * 1997-08-29 2001-09-04 ザ リセックス カンパニー インコーポレイテッド 糖尿病、高血糖症及び低血糖症の治療法
DE69904257T2 (de) * 1999-01-20 2003-04-17 N.V. Nutricia, Zoetermeer Säuglingsnährpräparat
DE19906379B4 (de) * 1999-02-16 2006-05-18 Huss, Manfred Herstellung eines aggregierten Molkenproteinprodukts
GB0302929D0 (en) * 2003-02-10 2003-03-12 Inst Of Child Health Nutrient composition
WO2005000325A2 (en) * 2003-06-30 2005-01-06 Nestec S.A. Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
CN1860131A (zh) * 2003-08-30 2006-11-08 雀巢技术公司 来自胶束酪蛋白的酸溶性蛋白质
EP1839492B1 (en) 2006-03-27 2011-09-14 Nestec S.A. Whey protein micelles
MY153295A (en) * 2004-09-29 2015-01-29 Nestec Sa Nanoparticulated whey proteins
DE602005026456D1 (de) 2004-12-27 2011-03-31 Nestec Sa Verwendung von säuglingsnahrung mit reduziertem proteingehalt
US20090203592A1 (en) * 2005-07-01 2009-08-13 N.V. Nutricia Infant nutrition with hydrolised proteins
AU2006327995B2 (en) 2005-12-23 2012-09-13 N.V. Nutricia Infant nutritional compositions for preventing obesity
DE602006015164D1 (de) * 2006-03-27 2010-08-12 Nestec Sa Kosmetische Verwendung von Molkeproteinmizellen
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
CN101438738A (zh) * 2007-11-23 2009-05-27 内蒙古蒙牛乳业（集团）股份有限公司 一种降血糖的酸奶及其生产方法
ES2715783T3 (es) 2008-10-17 2019-06-06 Nestec Sa Método para preparar composiciones de proteína de suero de leche y composición obtenible mediante el mismo
CN102917604B (zh) * 2010-03-12 2015-01-07 雀巢产品技术援助有限公司 掩蔽营养素味道的组合物及其制备方法

Also Published As

Publication number Publication date
EP2779846A1 (en) 2014-09-24
MX2014004802A (es) 2015-12-03
ES2643892T3 (es) 2017-11-27
AU2012324887B2 (en) 2015-10-29
CL2014000865A1 (es) 2014-08-18
AU2012324887A1 (en) 2014-04-03
EP2779846B1 (en) 2017-09-06
BR112014009225A2 (pt) 2017-06-13
EP2583562A1 (en) 2013-04-24
WO2013057233A1 (en) 2013-04-25
RU2014120428A (ru) 2015-11-27
CN103906440A (zh) 2014-07-02
US20140287056A1 (en) 2014-09-25
BR112014009225A8 (pt) 2017-06-20
US10028978B2 (en) 2018-07-24
RU2616525C2 (ru) 2017-04-17
CN103906440B (zh) 2016-09-21

Similar Documents

Publication Publication Date Title
MX350866B (es) Uso de micelas de proteina de suero de leche para infantes en riesgo de obesidad o diabetes.
MX2014015423A (es) Analogos de peptido de exedina-4.
MX2015008114A (es) Derivados de exendina-4.
PH12015500688A1 (en) Exendin-4 derivatives as dual glp1/glucagon agonists
CL2013000594A1 (es) Composicion que comprende hidrolizado de proteina en base lactea que proviene del tratamiento de una solucion de un material proteinaceo de base lactea con al menos una endopeptidasa tipo tripsina, y una endopeptidasa tipo quimotripsina; uso de dicha composicion como fórmula infantil o complemento alimenticio para inducción de tolerancia oral en infantes o pacientes que lo necesitan, o para reducir el riesgo de alergias.
MX2016013244A (es) Derivados de exendina-4 como agonistas peptidicos duales del receptor de glp-1/glucagon.
MX2016013243A (es) Agonistas peptídicos duales de los receptores de glp-1/glucagón derivados de la exendina-4.
MX2016003945A (es) Composiciones y formulaciones para la prevencion y tratamiento de la diabetes y la obesidad y los metodos de produccion y uso en el control de la glucosa y calorias.
MX366405B (es) Uso de peptidos glp-1 de accion prolongada.
NZ746784A (en) Glucagon and glp-1 co-agonists for the treatment of obesity
MX2013013307A (es) Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2.
EA201791611A1 (ru) Лечение пациентов детского возраста с сахарным диабетом 2 типа с помощью ликсисенатида
PL2696871T3 (pl) Aklidyna do zastosowania w poprawie jakości snu u pacjentów ze schorzeniami układu oddechowego
BR112014009414A2 (pt) uso de micelas de proteína de soro do leite para melhorar o perfil de insulina em pacientes diabéti-cos
PH12016500950A1 (en) Infant nutrition for improvement in insulin sensitivity later in life
WO2012104838A8 (en) Use of hgh for the treatment of small for gestational age infants under two years of age
TH160951A (th) การใช้เวย์โปรตีนไมเซลล์สำหรับทารกที่เสี่ยงต่อโรคอ้วนหรือเบาหวาน
PH12016502055A1 (en) Delivery mode specific synthetic nutritional compositions and nutritional systems comprising them
MX2019008148A (es) Uso de peptidos glp-1 de accion prolongada.
UA97667U (uk) Спосіб лікування транзиторної лактазної недостатності у дітей грудного віку
MX2014003447A (es) Solucion nutraceutica a base de inulina de agave y metodo de uso para aliviar los sintomas relacionados con la encefalopatia hepatica en pacientes con cirrosis hepatica.
UA101726C2 (ru) Средство для профилактики и лечения сахарного диабета
UA97054C2 (ru) Способ комплексного лечения больных с зависимостью вследствие употребления психоактивных веществ
UA52520U (ru) Способ лечения нарушений функционального состояния кишечника у новорожденных и детей младенческого возраста
UA60147U (ru) Способ лечения больных хроническим некалькулезным холециститом с сопутствующим ожирением

Legal Events

Date Code Title Description
FG Grant or registration